Sabra Healthcare REIT (SBRA) Q4 2025: Shop Investments Surge to $450M, Pushing NOI Growth Outlook

Sabra’s decisive $450 million investment pace in senior housing shop assets marks a strategic pivot toward managed operational growth, with robust occupancy and NOI expansion driving 2026 guidance. Portfolio repositioning and disciplined capital allocation are unlocking margin gains even as competition intensifies and skilled nursing remains a minority focus. With a deep operational bench and a strong balance sheet, Sabra is positioned to capitalize on sector tailwinds while navigating evolving market dynamics.

Summary

  • Shop-Focused Capital Deployment: Senior housing investments dominate the pipeline, driving outsized NOI growth.
  • Margin Expansion Momentum: Occupancy gains and muted expense growth fuel higher cash flow conversion.
  • Operational Discipline: Deep operator expertise and stable leverage underpin Sabra’s execution edge in a crowded market.

Business Overview

Sabra Healthcare REIT is a healthcare real estate investment trust (REIT) specializing in senior housing and skilled nursing facilities. The company generates revenue primarily through rent from triple net leased properties and direct operating income from its managed senior housing (“shop”) portfolio. Major segments include managed senior housing, triple net senior housing, and skilled nursing, with a strategic emphasis on expanding the shop portfolio for higher-margin, direct-operating growth.

Performance Analysis

Sabra’s Q4 results reflect a sharp acceleration in capital deployment and operational execution within its managed senior housing segment. The company invested over $150 million in the quarter, bringing 2025’s total to approximately $450 million, with an estimated initial cash yield of 7.5% and a focus on newer, high-occupancy assets. Sequential revenue growth in the managed portfolio reached 15.8%, with cash NOI up 18.4% and margin expansion of 60 basis points, underscoring the strength of both organic and external growth levers.

Same-store managed senior housing delivered 6.4% YoY revenue growth and a 12.6% YoY increase in cash NOI, driven by occupancy gains in both U.S. and Canadian portfolios. The Canadian segment, in particular, saw a 300 basis point occupancy increase to 94.2%, sustaining its outperformance over the U.S. portfolio. Cash NOI from triple net assets declined $1.3 million sequentially due to asset transitions, but the managed shop’s $5.5 million NOI gain more than offset this. G&A expense spiked due to performance-based compensation, but normalized levels remain in line with prior quarters. Leverage held steady at 5.0x net debt/EBITDA, with $1.2 billion in liquidity and no near-term maturity risk.

  • Pipeline Acceleration: $240 million in awarded deals are in process, nearly all focused on shop assets, with volume expected to materially exceed 2025.
  • Occupancy Inflection: Shop portfolio occupancy rose to 87.9%, with the U.S. at 84.7% and Canada at 94.2%, supporting margin gains.
  • Dividend Coverage: The quarterly dividend payout ratio stands at 79% of normalized AFFO, indicating sustainable distribution levels.

Sabra’s performance signals a successful shift toward higher-growth, higher-margin managed assets, with disciplined capital allocation and operational leverage poised to drive further upside as occupancy approaches the low 90% range in 2026.

Executive Commentary

"Our pipeline continues to be robust. We completed approximately $450 million investments for 2025. We had discussed on our last call exceeding $500 million. A couple of those deals fell over into 2026, but no deals fell out, so we're closing on everything that we said we would close on on our last call."

Rick Matros, CEO, President, and Chair

"Cash NOI from our triple net portfolio decreased $1.3 million from the third quarter, while cash NOI from our managed senior housing portfolio increased $5.5 million for a net sequential increase of $4.2 million. The $5.5 million increase was primarily the result of investment activity completed during the third and fourth quarters together with sequential growth in our same store portfolio."

Michael Costa, Chief Financial Officer

Strategic Positioning

1. Shop Portfolio Expansion

Sabra is doubling down on managed senior housing (“shop”) as its core growth engine, with the lion’s share of new investment and deal flow focused on this segment. The company’s 2025 investment tally reached $450 million, and awarded deals for early 2026 are similarly concentrated in shop assets. Management expects shop investments to drive outsized NOI and margin expansion, leveraging operating scale and occupancy gains.

2. Disciplined Capital Allocation and Balance Sheet Strength

Leverage discipline and proactive equity issuance underpin Sabra’s ability to fund growth while maintaining financial flexibility. The company’s net debt/EBITDA stands at 5.0x, with no material debt maturities until 2028 and $1.2 billion in liquidity. Use of forward equity contracts at attractive pricing enables pipeline execution without incremental leverage risk.

3. Margin Expansion and Operational Leverage

Occupancy gains are translating into margin expansion, particularly as incremental occupancy above 90% flows through to NOI with minimal expense growth. Canadian assets are leading on occupancy and pricing power, while U.S. assets have meaningful runway as they approach the low 90% range. Management expects muted expense growth in 2026, supporting continued cash flow conversion improvement.

4. Competitive Positioning and Operator Expertise

Sabra’s decade-long experience in shop operations and a deep operator-centric asset management team provide a competitive moat as more REITs enter the managed senior housing space. The company’s business intelligence and data analytics capabilities enhance its ability to optimize performance and adapt to rising acuity trends across its portfolio.

5. Selective Approach to Skilled Nursing

Skilled nursing remains a minor focus, with only $20 million of awarded deals in the current pipeline and investments largely limited to existing operator relationships. Regulatory and reimbursement environments are stable, but Sabra’s strategy clearly prioritizes senior housing shop for growth and returns.

Key Considerations

Sabra’s Q4 2025 results highlight a strategic inflection toward managed senior housing, supported by robust capital deployment, operational excellence, and balance sheet discipline. The company is positioned to harness sector tailwinds while navigating a more competitive acquisition landscape.

Key Considerations:

  • Shop Asset Ramp: New acquisitions typically enter the portfolio with mid-80% occupancy, offering substantial growth runway as they stabilize and transition into same-store pools.
  • Canadian Outperformance: Canadian shop assets continue to deliver higher occupancy and pricing power, with limited new supply and sustained demand supporting the trend.
  • Expense Control: Expense growth in managed senior housing is expected to remain below inflation as occupancy climbs, enhancing margin leverage.
  • Cap Rate Compression: Increased competition is compressing cap rates, but Sabra continues to source deals in the 7% range by focusing on newer, high-quality assets.
  • Preferred Equity Development Program: Sabra is selectively providing preferred equity for new development, targeting double-digit returns and future pipeline optionality.

Risks

Sabra faces intensifying competition for shop assets as more REITs and private equity investors target the sector, potentially pressuring acquisition yields and increasing execution risk. Skilled nursing remains exposed to regulatory and reimbursement changes, though current trends are stable. Expense surprises or slower-than-expected occupancy ramp in new acquisitions could dilute margin expansion. Capex requirements, especially deferred maintenance in shop assets, require ongoing scrutiny to avoid drag on returns.

Forward Outlook

For Q1 and early Q2 2026, Sabra expects to close on $240 million in awarded investments, with the majority in shop assets.

  • Normalized FFO per share guidance for 2026: $1.49 to $1.53
  • Normalized AFFO per share guidance for 2026: $1.55 to $1.59

Full-year 2026 guidance implies approximately 5% growth in both normalized FFO and AFFO per share, with low to mid-teens NOI growth expected in the same-store managed senior housing portfolio. Guidance assumes no uncompleted acquisitions, dispositions, or capital markets activity. Management emphasized continued robust deal flow, stable rent coverage, and disciplined expense control as key drivers for the year.

  • Shop occupancy targeted to move into the low 90% range
  • Dividend payout to remain well-covered by AFFO

Takeaways

Sabra’s Q4 2025 performance cements its pivot toward managed senior housing, leveraging capital deployment, operational expertise, and a robust pipeline to drive NOI and margin expansion into 2026.

  • Strategic Shift: The company’s accelerated shop investment pace and operational leverage are set to deliver above-peer NOI growth and margin gains.
  • Execution Edge: Sabra’s deep operator bench and data-driven asset management differentiate it as competition rises in the shop segment.
  • Watch for Occupancy Ramp: The pace of occupancy gains in both new and transitioning shop assets will be a key determinant of forward NOI and cash flow upside.

Conclusion

Sabra Healthcare REIT’s Q4 2025 results validate its shop-focused growth strategy, with disciplined capital allocation and operational execution yielding tangible NOI and margin gains. The company’s balance sheet strength and operator-centric approach position it to outperform in a consolidating and increasingly competitive senior housing market.

Industry Read-Through

Sabra’s results reinforce the sector’s pivot toward managed senior housing as the primary growth vector, with direct operating models delivering superior margin leverage compared to traditional triple net leases. Cap rate compression and elevated competition signal a new phase of sector consolidation, rewarding REITs with deep operational expertise and robust balance sheets. The Canadian market’s outperformance highlights the impact of supply constraints and demographic tailwinds, while U.S. assets retain significant upside as demand recovers. Other healthcare REITs and private equity entrants will need to build operational infrastructure and data capabilities to compete effectively in the evolving shop landscape. Margin expansion, disciplined capital allocation, and strategic asset selection will remain key differentiators as the market matures.